FdaApplication
ANDA 211248
Identifiers
- fda_app_no: ANDA211248
Properties
| Property | Value |
|---|---|
| applicant_name | YILING PHARMACEUTICAL LTD |
| application_type | ANDA |
| approval_date | 2021-11-02 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PAROXETINE HYDROCHLORIDE | PAROXETINE HYDROCHLORIDE | EQ 10MG BASE | TABLET;ORAL |
| PAROXETINE HYDROCHLORIDE | PAROXETINE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL |
| PAROXETINE HYDROCHLORIDE | PAROXETINE HYDROCHLORIDE | EQ 40MG BASE | TABLET;ORAL |
| PAROXETINE HYDROCHLORIDE | PAROXETINE HYDROCHLORIDE | EQ 20MG BASE | TABLET;ORAL |
4 products